Priority Date: 17.08.12 (JP 20120181225)

ORALLY ADMINISTRABLE VIRIDIOFUNGIN DERIVATIVE HAVING ANTI-HCV ACTIVITY

  • Application ID: EP13829884
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 186 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 17.08.2012 - Priority Date (JP 20120181225)
  • 20.02.2014 - Publication A1 (WO2014027696)
  • 24.06.2015 - Publication A1 (EP2886530)